Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis

NovaDigm Therapeutics, Inc. · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
vulvovaginal candidiasis, recurrent vulvovaginal candidiasis, candida, ndv3, vaginal thrush, chronic yeast infection, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 891707
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.